NYSE$UHT

Universal Health Realty Income Trust · Q4 2023 earnings

Q4 2023 earnings · · Investor relations

Briefing

Reported a decrease in net income due to increased interest expenses and non-recurring items, partially offset by increased income from various properties.

Universal Health Realty Income Trust reported a net income of $3.6 million, or $0.26 per diluted share, for the fourth quarter of 2023, compared to $5.6 million, or $0.41 per diluted share, for the same period in 2022. Adjusted net income for Q4 2023 was $3.8 million, or $0.28 per diluted share, compared to $5.6 million, or $0.41 per diluted share in Q4 2022. FFO was $11.4 million, or $0.82 per diluted share, compared to $12.4 million, or $0.90 per diluted share in the prior year quarter.

  • Net income for Q4 2023 was $3.6 million, or $0.26 per diluted share.
  • Adjusted net income for Q4 2023 was $3.8 million, or $0.28 per diluted share.
  • FFO for Q4 2023 was $11.4 million, or $0.82 per diluted share.
  • A loss on divestiture of $232,000 was recorded in connection with the sale of a vacant specialty facility.

Headline financials

Total Revenue

$24.3M

Previous: $24.1M+0.8%
EPS (adj)

$0.28

Previous: $0.41-31.7%
Funds From Operations

$11.4M

No prior period
Capital Expenditures

$0.00

No prior period
Net Income

$3.59M

Previous: $5.63M-36.2%
Operating Income

$8.16M

Previous: $8.73M-6.6%
Gross Profit

$8.16M

Previous: $22.8M-64.3%
Stock-Based Comp

$203K

Previous: $189K+7.4%

Revenue & EPS history

UHT · Revenue · Quarterly

$24.3M

Q4 2023+0.8%vs Q4 2022

Revenue by segment

UHT · $658K total across 2 segments · Q3 2023

  • Other Revenue - Non-related parties
    $404K+82.8%
  • Other Revenue - UHS Facilities
    $254K-0.4%

Forward guidance

Universal Health Realty Income Trust looks forward to 2024 with optimism as they strive to add high quality investments to their existing portfolio of properties while maintaining their fundamental goal of providing a safe and reliable dividend stream to their shareholders.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 19 quarterly earnings reports · overlaid with Q4 2023

Historical avgQ4 2023

-0.0%

Avg return

Earnings day

-0.2%

Avg return

5 days after

+1.0%

Avg return

30 days after

52%

34 / 65 earnings

Positive

+12.7%

Q1 2020

Best reaction

-6.8%

Q3 2018

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+0.9%-0.8%
Q4 2025+0.2%-0.7%-9.7%
Q3 2025+2.1%+4.9%+12.7%
Q1 2025-0.5%+1.7%+2.2%
Q4 2024+0.8%+1.9%+3.0%
Q3 2024-2.9%-4.6%-2.2%
Q2 2024+2.5%+1.6%+5.1%
Q1 2024+0.8%+5.8%+10.1%
Q4 2023+0.2%-4.1%-9.7%
Q3 2023+1.1%-0.9%+3.4%
Q2 2023-3.4%-3.7%-5.2%
Q1 2023-5.9%-6.5%-8.3%
Q4 2022-1.5%-5.8%-11.9%
Q3 2022+5.3%+8.8%+15.6%
Q2 2022+2.3%+2.8%-0.1%
Q1 2022-3.1%-11.1%-7.3%
Q4 2021+1.2%+4.2%+3.4%
Q3 2021+0.5%-0.6%+2.2%
Q2 2021-0.7%-1.8%-3.7%
Q1 2021+0.2%-3.0%-0.0%
Q4 2020-6.1%-6.3%+7.8%
Q3 2020-2.3%+2.7%+14.5%
Q2 2020+0.7%+3.2%-0.1%
Q1 2020+12.7%+9.9%+5.9%
Q4 2019-6.6%-8.1%-21.6%
Q3 2019+3.7%+8.4%+0.7%
Q2 2019+1.6%+3.2%+5.6%
Q1 2019+3.8%+3.7%+8.0%
Q4 2018+0.3%+0.2%+1.1%
Q3 2018-6.8%-11.2%-6.2%
Q2 2018+0.8%+4.4%+15.6%
Q1 2018+4.1%+2.0%+3.1%
Q4 2017+3.0%+6.4%+8.6%
Q3 2017-0.8%-2.9%-0.2%
Q2 2017-5.6%-6.7%-10.0%
Q1 2017+0.3%+0.9%+3.0%
Q4 2016-0.1%-1.3%+0.5%
Q3 2016-4.1%-5.8%-0.3%
Q2 2016-1.1%+0.7%+3.5%
Q1 2016-1.5%
Q4 2015+0.6%
Q3 2015-0.1%
Q2 2015+0.7%
Q1 2015-2.3%
Q4 2014-0.7%
Q3 2014+1.4%
Q2 2014-1.1%
Q1 2014-0.2%
Q4 2013+1.6%
Q3 2013+1.9%
Q2 2013-0.5%
Q1 2013-1.9%
Q1 2011-0.2%
Q4 2012+1.7%
Q3 2012-1.7%
Q4 2011-1.0%
Q2 2012-1.0%
Q1 2012+0.6%
Q4 2009-1.2%
Q3 2010+0.0%
Q3 2011+0.0%
Q2 2011+0.3%
Q4 2010+0.3%
Q2 2010+0.3%
Q1 2010+4.0%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro